# Moderna Jumps 9% After Melanoma Data Wins Prestigious Slot

> Moderna stock surges 9% as Phase 3 melanoma trial data secures top presentation slot at major cancer conference
- Title: Moderna Jumps 9% After Melanoma Data Wins Prestigious Slot
- Summary: Moderna stock surges 9% as Phase 3 melanoma trial data secures top presentation slot at major cancer conference Market pricing the significance of a…
- Keywords: moderna, phase3, melanoma, presidential symposium, european society for medical oncology, intismeran autogene, pembrolizumab, biontech, merck, nasdaq:mrna, ibb, spy
- Source: 24/7 Wall St. — https://247wallst.com/investing/2026/09/21/moderna-surges-9-as-phase-3-melanoma-data-wins-presidential-symposium-slot-merck-and-biontech-edge-higher
- Author: David Moadel
- Published: 2026-09-21T15:45:55+00:00
- Read time: 1 min
- Topics: moderna, phase3, melanoma, presidential symposium, european society for medical oncology, intismeran autogene, pembrolizumab, biontech, merck, nasdaq:mrna, ibb, spy
## Presidential Symposium Slot
Moderna shares jumped 9% after its Phase 3 melanoma study earned a Presidential Symposium slot at the European Society for Medical Oncology conference in Madrid

> Moderna's Phase 3 adjuvant melanoma study for intismeran autogene was selected for a Presidential Symposium slot at the European Society for Medical Oncology congress
## Market Reaction
Moderna stock reached $167.90, up 9% while Merck rose 1% and BioNTech gained 2% on the news
## What the Slot Means
The Presidential Symposium is the highest-profile presentation slot at the conference, reserved for data expected to change clinical practice
## Why No New Data
The melanoma result was first reported in August, with today's announcement adding a fixed date and venue rather than new efficacy results
## Merck and BioNTech Moves
Merck, the pembrolizumab partner, moved modestly while BioNTech gained on platform read-through without broader category impact
## Next Data Window
Moderna will present the Phase 3 dataset on October 24 with an investor webcast, creating concentrated event risk
## Market Pricing
The market is pricing the significance of the Presidential Symposium slot without new data, reflecting expectations of clinical impact
## Key takeaway

Market pricing the significance of a Presidential Symposium slot at a major oncology conference without new data